Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_assertion type Assertion NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_head.
- NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_provenance.
- NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_assertion evidence source_evidence_literature NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_provenance.
- NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_assertion SIO_000772 18523305 NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_provenance.
- NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_assertion wasDerivedFrom befree-20150227 NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_provenance.
- NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_assertion wasGeneratedBy ECO_0000203 NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_provenance.